How to find an FDA product code for a medical device
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Medical-device intelligence
FDA product code OCC: Respiratory Virus Panel Nucleic Acid Assay System. View classification details, related manufacturers, 510(k) clearances, and recall records.
A respiratory viral panel multiplex nucleic acid assay is a qualitative in vitro diagnostic device intended to simultaneously detect and identify multiple viral nucleic acids extracted from human respiratory specimens or viral culture. The detection and identification of a specific viral nucleic acid from individuals exhibiting signs and symptoms of respiratory infection aids in the diagnosis of respiratory viral infection when used in conjunction with other clinical and laboratory findings. The device is intended for detection and identification of a combination of the following viruses: Influenza A and Influenza B, Influenza A subtype H1 and Influenza A subtype H3, Respiratory Syncytial Virus subtype A and Respiratory Syncytial Virus subtype B, Parainfluenza 1, Parainfluenza 2, and Parainfluenza 3 virus, Human Metapneumovirus, Rhinovirus, and Adenovirus.Explore microbiology records →
81 clearance records and 25 recall records in the covered releases, across 34 source company names and 1 product codes. Dated history runs from Jan 4, 2008 to Nov 4, 2026.
| Month | 510(k) decisions | Recall initiations |
|---|---|---|
| October 2025 | 0 | 0 |
| November 2025 | 0 | 0 |
| December 2025 | 0 | 0 |
| January 2026 | 0 | 0 |
| February 2026 | 0 | 0 |
| March 2026 | 0 | 0 |
| April 2026 | 0 | 0 |
| May 2026 | 1 | 0 |
| June 2026 | 0 | 0 |
| July 2026 | 0 | 0 |
| August 2026 | 1 | 0 |
| September 2026 | 0 | 0 |
| October 2026 | 1 | 0 |
| Code and FDA device name | Clearances | Recalls |
|---|---|---|
| OCC · Respiratory Virus Panel Nucleic Acid Assay System | 81 | 25 |
| Device / record | Company in FDA record | Source | Source date |
|---|---|---|---|
| MODIFICATION TO PROFLU+ ASSAYK092500 · OCC | Prodesse, Inc. | 510(k) | Aug 20, 2009FDA decision date |
| XTAG RESPIRATORY VIRAL PANEL, MODELS I019A0110, I019C011, I019D0112, I019E0113, S019-0116K091667 · OCC | Luminex Molecular Diagnostics, Inc. | 510(k) | Jun 25, 2009FDA decision date |
| VERIGENE RESPIRATORY VIRUS NUCLEIC ACID TESTK083088 · OCC | Nanosphere, Inc. | 510(k) | May 1, 2009FDA decision date |
| XTAG RESPIRATORY VIRAL PANELK081483 · OCC | Luminex Molecular Diagnostics, Inc. | 510(k) | Jun 25, 2008FDA decision date |
| MODIFICATION TO PROFLU+ ASSAYK081030 · OCC | Prodesse, Inc. | 510(k) | May 2, 2008FDA decision date |
| PROFLU+ ASSAYK073029 · OCC | Prodesse, Inc. | 510(k) | Jan 4, 2008FDA decision date |
Search device names, compare classification definitions, and distinguish a product code from a clearance number or UDI.
Read the guide →Understand the K number, applicant, decision date, product code, and limits of the public clearance record.
Read the guide →FDA dataset:
Last successful check: Nov 22, 2026
Source classifications may change.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset monthly.
FDA dataset:
Last successful check: Nov 22, 2026
FDA publishes this dataset weekly.
Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.